Cargando…

Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study

BACKGROUND: Colonization or infection with multi-drug resistant (MDR) bacteria is considered detrimental to the outcome of neurological and neurosurgical early rehabilitation patients. METHODS: In a German multi-center study, 754 neurological early rehabilitation patients were enrolled and and revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Rollnik, J. D., Bertram, M., Bucka, C., Hartwich, M., Jöbges, M., Ketter, G., Leineweber, B., Mertl-Rötzer, M., Nowak, D. A., Platz, T., Scheidtmann, K., Thomas, R., von Rosen, F., Wallesch, C. W., Woldag, H., Peschel, P., Mehrholz, J., Pohl, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359920/
https://www.ncbi.nlm.nih.gov/pubmed/28320357
http://dx.doi.org/10.1186/s12883-017-0833-2
_version_ 1782516485900468224
author Rollnik, J. D.
Bertram, M.
Bucka, C.
Hartwich, M.
Jöbges, M.
Ketter, G.
Leineweber, B.
Mertl-Rötzer, M.
Nowak, D. A.
Platz, T.
Scheidtmann, K.
Thomas, R.
von Rosen, F.
Wallesch, C. W.
Woldag, H.
Peschel, P.
Mehrholz, J.
Pohl, M.
author_facet Rollnik, J. D.
Bertram, M.
Bucka, C.
Hartwich, M.
Jöbges, M.
Ketter, G.
Leineweber, B.
Mertl-Rötzer, M.
Nowak, D. A.
Platz, T.
Scheidtmann, K.
Thomas, R.
von Rosen, F.
Wallesch, C. W.
Woldag, H.
Peschel, P.
Mehrholz, J.
Pohl, M.
author_sort Rollnik, J. D.
collection PubMed
description BACKGROUND: Colonization or infection with multi-drug resistant (MDR) bacteria is considered detrimental to the outcome of neurological and neurosurgical early rehabilitation patients. METHODS: In a German multi-center study, 754 neurological early rehabilitation patients were enrolled and and reviewed in respect to MDR status, length of stay (LOS) and the following outcome variables: Barthel Index (BI), Early Rehabilitation Index (ERI), Glasgow Outcome Score Extended (GOSE), Coma Remission Scale (CRS), Functional Ambulation Categories (FAC). RESULTS: The mean age of the study population was 68.0 ± 14.8 years. Upon admission, the following prevalence for MDRs was observed: MRSA (methicillin resistant staphylococcus aureus) 7.0% (53/754), ESBL- (extended spectrum beta-lactamase) producing bacteria strains 12.6% (95/754), VRE (vancomycin resistant enterococci) 2.8% (21/754). Patients colonized or infected with MDR bacteria (MDR+) were significantly more frequently diagnosed with a critical illness polyneuropathy – CIP – than non-colonized (MDR-) patients: 29.0% vs. 14.8%. In addition, they were more frequently mechanically ventilated (MDR+: 55/138, 39.9%; MDR- 137/616, 22.2%). MDR+ patients were referred to rehabilitation earlier, had a longer LOS in early rehabilitation, lower BI on admission and at discharge, lower ERI on admission and lower CRS at discharge than MDR- patients. There was a highly significant correlation of the BI upon admission with the BI at discharge (r(s) = 0.492, p < 0.001). GOSE at discharge differed significantly between both groups (χ (2)-test, p < 0.01). Perhaps of greatest importance, mortality among MDR+ was higher in comparison to MDR- (18.1% vs. 7.6%). CONCLUSIONS: The outcome of neurological early rehabilitation patients colonized or infected with MDR bacteria including MRSA or ESBL producing strains is significantly poorer than by non-colonized patients. There is some evidence that the poor outcome could be related to the higher morbidity and lower functional status upon admission.
format Online
Article
Text
id pubmed-5359920
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53599202017-03-22 Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study Rollnik, J. D. Bertram, M. Bucka, C. Hartwich, M. Jöbges, M. Ketter, G. Leineweber, B. Mertl-Rötzer, M. Nowak, D. A. Platz, T. Scheidtmann, K. Thomas, R. von Rosen, F. Wallesch, C. W. Woldag, H. Peschel, P. Mehrholz, J. Pohl, M. BMC Neurol Research Article BACKGROUND: Colonization or infection with multi-drug resistant (MDR) bacteria is considered detrimental to the outcome of neurological and neurosurgical early rehabilitation patients. METHODS: In a German multi-center study, 754 neurological early rehabilitation patients were enrolled and and reviewed in respect to MDR status, length of stay (LOS) and the following outcome variables: Barthel Index (BI), Early Rehabilitation Index (ERI), Glasgow Outcome Score Extended (GOSE), Coma Remission Scale (CRS), Functional Ambulation Categories (FAC). RESULTS: The mean age of the study population was 68.0 ± 14.8 years. Upon admission, the following prevalence for MDRs was observed: MRSA (methicillin resistant staphylococcus aureus) 7.0% (53/754), ESBL- (extended spectrum beta-lactamase) producing bacteria strains 12.6% (95/754), VRE (vancomycin resistant enterococci) 2.8% (21/754). Patients colonized or infected with MDR bacteria (MDR+) were significantly more frequently diagnosed with a critical illness polyneuropathy – CIP – than non-colonized (MDR-) patients: 29.0% vs. 14.8%. In addition, they were more frequently mechanically ventilated (MDR+: 55/138, 39.9%; MDR- 137/616, 22.2%). MDR+ patients were referred to rehabilitation earlier, had a longer LOS in early rehabilitation, lower BI on admission and at discharge, lower ERI on admission and lower CRS at discharge than MDR- patients. There was a highly significant correlation of the BI upon admission with the BI at discharge (r(s) = 0.492, p < 0.001). GOSE at discharge differed significantly between both groups (χ (2)-test, p < 0.01). Perhaps of greatest importance, mortality among MDR+ was higher in comparison to MDR- (18.1% vs. 7.6%). CONCLUSIONS: The outcome of neurological early rehabilitation patients colonized or infected with MDR bacteria including MRSA or ESBL producing strains is significantly poorer than by non-colonized patients. There is some evidence that the poor outcome could be related to the higher morbidity and lower functional status upon admission. BioMed Central 2017-03-20 /pmc/articles/PMC5359920/ /pubmed/28320357 http://dx.doi.org/10.1186/s12883-017-0833-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rollnik, J. D.
Bertram, M.
Bucka, C.
Hartwich, M.
Jöbges, M.
Ketter, G.
Leineweber, B.
Mertl-Rötzer, M.
Nowak, D. A.
Platz, T.
Scheidtmann, K.
Thomas, R.
von Rosen, F.
Wallesch, C. W.
Woldag, H.
Peschel, P.
Mehrholz, J.
Pohl, M.
Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study
title Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study
title_full Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study
title_fullStr Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study
title_full_unstemmed Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study
title_short Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study
title_sort outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a german multi-center study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359920/
https://www.ncbi.nlm.nih.gov/pubmed/28320357
http://dx.doi.org/10.1186/s12883-017-0833-2
work_keys_str_mv AT rollnikjd outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT bertramm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT buckac outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT hartwichm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT jobgesm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT ketterg outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT leineweberb outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT mertlrotzerm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT nowakda outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT platzt outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT scheidtmannk outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT thomasr outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT vonrosenf outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT walleschcw outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT woldagh outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT peschelp outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT mehrholzj outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy
AT pohlm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy